Intensive care monitoring after total joint replacement
|
A. F. Kamath, C. L. McAuliffe, J. T. Gutsche, L. M. Kosseim, E. L. Hume, K. D. Baldwin, Z. Kornfield, C. L. Israelite |
2013 |
Bone Joint J 2013;95-B, Supple A:74–6. |
Open
|
Thromboprophylaxis for patients undergoing joint replacement
|
R. L. Barrack |
2014 |
The Bone & Joint Journal Vol. 96-B, No. 1 |
Open
|
Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement
|
B. V. Bloch, V. Patel, A. J. Best |
2014 |
Bone Joint J 2014;96-B:122–6. |
Open
|
Is there any benefit in pre-operative urinary analysis before elective total joint replacement?
|
C. Bouvet, A. Lübbeke, C. Bandi, L. Pagani, R. Stern, P. Hoffmeyer, I. Uçkay |
2014 |
Bone Joint J 2014;96-B:390–4. |
Open
|
Antibiotic-related acute kidney injury in patients undergoing elective joint replacement
|
O. Bailey, M. S. Torkington, I. Anthony, J. Wells, M. Blyth, B. Jones |
2014 |
Bone Joint J 2014;96-B:395–8. |
Open
|
Interplay between surface properties of standard, vitamin E blended and oxidised ultra high molecular weight polyethylene used in total joint replacement and adhesion of Staphylococcus aureus and Escherichia coli
|
G. Banche, V. Allizond, P. Bracco, A. Bistolfi, M. Boffano, A. Cimino, E. M. Brach del Prever, A. M. Cuffini |
2014 |
Bone Joint J 2014;96-B:497–501. |
Open
|
The Unified Classification System (UCS): improving our understanding of periprosthetic fractures
|
C. P. Duncan, F. S. Haddad |
2014 |
Bone Joint J 2014;96-B:713–16. |
Open
|
Interleukin-6 in two-stage revision arthroplasty
|
S. Hoell, L. Borgers, G. Gosheger, R. Dieckmann, D. Schulz, J. Gerss, J. Hardes |
2015 |
Bone Joint J 2015;97-B:71–5. |
Open
|
Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients
|
H. Wafa, R. J. Grimer, K. Reddy, L. Jeys, A. Abudu, S. R. Carter, R. M. Tillman |
2015 |
Bone Joint J 2015;97-B:252–7. |
Open
|
The use of patient-reported outcomes after routine arthroplasty
|
O. Rolfson, H. Malchau |
2015 |
Bone Joint J 2015;97-B:578–81. |
Open
|
Periprosthetic joint infection
|
J. Parvizi, F. S. Haddad |
2015 |
The Bone & Joint Journal Vol. 97-B, No. 9 |
Open
|
The management of periprosthetic infections in the future
|
D. A. George, V. Gant, F. S. Haddad |
2015 |
Bone Joint J 2015;97-B:1162–9. |
Open
|
Use of leucocyte esterase reagent strips in the diagnosis or exclusion of prosthetic joint infection
|
R. Shafafy, W. McClatchie, K. Chettiar, K. Gill, R. Hargrove, S. Sturridge, A. Guyot |
2015 |
Bone Joint J 2015;97-B:1232–6. |
Open
|
The treatment of arthritis of the wrist
|
J. S. Logan, D. Warwick |
2015 |
Bone Joint J 2015;97-B:1303–8. |
Open
|
Which patients need critical care intervention after total joint arthroplasty?
|
P. M. Courtney, C. M. Melnic, J. Gutsche, E. L. Hume, G-C. Lee |
2015 |
Bone Joint J 2015;97-B:1512–18. |
Open
|
Minimising the risk of infection
|
S. Heller, M. Rezapoor, J. Parvizi |
2016 |
Bone Joint J 2016;98-B(1 Suppl A):18–22. |
Open
|
Prophylactic peri-operative local antibiotic irrigation
|
L. A. Whiteside |
2016 |
Bone Joint J 2016;98-B(1 Suppl A):23–6. |
Open
|
Can National Joint Registries play a role in improving our understanding of periprosthetic infections?
|
F. S. Haddad, D. A. George |
2016 |
The Bone & Joint Journal Vol. 98-B, No. 3 |
Open
|
Aspirin – have we had the answer all along?
|
F. S. Haddad |
2016 |
The Bone & Joint Journal Vol. 98-B, No. 5 |
Open
|
The impact of frailty on outcomes and healthcare resource usage after total joint arthroplasty
|
D. I. McIsaac, P. E. Beaulé, G. L. Bryson, C. Van Walraven |
2016 |
Bone Joint J 2016;98-B:799–805. |
Open
|
Medium-term outcomes of the Universal-2 total wrist arthroplasty in patients with rheumatoid arthritis
|
R. Badge, K. Kailash, D. R. Dickson, S. Mahalingam, A. Raza, A. Birch, D. Nuttall, S. R. Murali, M. J. Hayton, S. Talwalkar, A. C. Watts, I. A. Trail |
2016 |
Bone Joint J 2016;98-B:1642–7. |
Open
|
Qualitative α-defensin test (Synovasure) for the diagnosis of periprosthetic infection in revision total joint arthroplasty
|
I. K. Sigmund, J. Holinka, J. Gamper, K. Staats, C. Böhler, B. Kubista, R. Windhager |
2017 |
Bone Joint J 2017;99-B:66–72. |
Open
|
Prevention of periprosthetic joint infection
|
J. Parvizi, N. Shohat, T. Gehrke |
2017 |
Bone Joint J 2017;99-B(4 Supple B):3–10. |
Open
|
Synovial calprotectin
|
M. Wouthuyzen-Bakker, J. J. W. Ploegmakers, G. A. Kampinga, L. Wagenmakers-Huizenga, P. C. Jutte, A. C. Muller Kobold |
2017 |
Bone Joint J 2017;99-B:660–5. |
Open
|
Does tantalum exhibit any intrinsic antimicrobial or antibiofilm properties?
|
P. L. Harrison, T. Harrison, I. Stockley, T. J. Smith |
2017 |
Bone Joint J 2017;99-B:1153–6. |
Open
|